Award
Delivery Order #SPE2DR26FMJU5
Short-term Delivery Order for Midazolam Hydrochloride to Support Medical Needs
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FMJU5
NAICS
424210
This award represents a delivery order contract granted to DMS Pharmaceutical Group Inc., a specialized pharmaceutical service provider. The contract procures Midazolam Hydrochloride, a critical pharmaceutical product, to meet immediate and short-term healthcare operational needs. It is a subordinate agreement under an existing indefinite delivery vehicle contract, which supports ongoing pharmaceutical supply to a government entity. The significance of this award lies in its contribution to maintaining uninterrupted access to essential medications, thereby supporting medical readiness and patient care. The scope includes the timely delivery of the specified pharmaceutical within a brief performance window. While details on competitive bidding are not specified, the award follows a previously established contract framework with DMS Pharmaceutical Group. The contract's timeline is concise, with the delivery expected over a few days, underscoring its role in addressing urgent pharmaceutical requirements.
Description
4571140568! MIDAZOLAM HYDROCHLORI